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272 The Journal of Thoracic and Cardbjective: Recent evidence suggests that the adult heart contains stem cells that are
apable of self-renewal as well as multilineage differentiation. However, their
nherent capacity for self-renewal is limiting to cell replacement applications.
ntegrin-linked kinase is a multifunctional protein kinase that activates Wnt target
enes implicated in the symmetric replication of embryonic stem cells.
ethods: Primary cultures derived from human fetal cardiac tissue (19-22 weeks’
estation) were grown in serum-free media and evaluated for the presence of cardiac
rogenitor cells. The effect of integrin-linked kinase was ascertained by adenoviral
verexpression.
esults: Cultures infected with wild-type integrin-linked kinase yielded a significant
P  .001), approximately 5-fold increase in both the absolute number and the
requency of c-Kit-positive, myosin-negative cells. Cardiospheres, comprised on
orphologically homogeneous, anchorage-independent cells, were reproducibly
resent at days 7 to 10 and formed derivative cardiospheres in multiple passages.
ntegrin-linked kinase infection of primary cardiac cell cultures resulted in a greater
umber of primary spheres at each cell density tested, compared with untreated and
irus controls (P  .001). Secondary spheres transferred to differentiation medium
nd 5-aza-deoxycytodine (10 mol/L) generated cells exhibiting biochemical evi-
ence of differentiation into cardiomyocytes, smooth muscle cells, and endothelial
ells.
onclusions: This study demonstrates that self-renewing cardiospheres generated
rom human fetal cardiac cells are composed of cells exhibiting the properties of
tem cells, including the capacity for self-renewal and multilineage differentiation.
ur results suggest that integrin-linked kinase promotes stem cell amplification and
an be applied therapeutically to overcome a major limitation in the field of cardiac
egenerative medicine.
ecent studies have challenged the traditional thinking that the adult mam-
malian heart lacks inherent regenerative capacity. Cardiac stem cells derived
from bone marrow or niches within the heart have been identified and shown
o participate in the regeneration of myocardium in vivo.1-3 Tissue-resident cardiac
rogenitor cells expressing various stem cell markers such as Sca-1, MDR-1, and
-Kit, exhibit the hallmarks of adult stem cells: self-renewal, clonogenicity, and
ultilineage differentiation. However, the population of progenitor cells in the heart
s very low, and the inability to expand this population of cells in vitro or in vivo
epresents a major barrier to therapeutic stem cell applications.
Integrin-linked kinase (ILK) is a multifunctional protein kinase that coordinates
ignal transduction by integrins and growth factor receptors and serves as a nodal
egulator of protein kinase cascades important to cell proliferation, differentiation,
nd apoptosis.4,5 ILK functions as the effector of phosphoinositide-3’-OH kinase
iovascular Surgery ● December 2006
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Dignaling, following distinct signal inputs from integrins
nd growth factor receptor tyrosine kinases.6,7 ILK also
nhibits glycogen synthase kinase-3ß (GSK-3ß),5,8 which
eads to the nuclear accumulation of -catenin. This, in turn,
eads to the activation of Wnt target genes implicated in the
aintenance and symmetric replication of embryonic stem
ells, as well as their more tissue- and lineage-restricted
rogeny. The canonical Wnt/-catenin signaling pathway
as been shown to be important in both embryonic and adult
tem cell maintenance and self-renewal in hematopoetic,
astrointestinal, and neural tissues,9-12 although this path-
ay has not been studied in cardiac stem cells.
Here we show that the overexpression of ILK in human
etal cardiac tissue in vitro increases the population of cardiac
tem cells, which exhibit self-renewal and multilineage dif-
erentiation. Our results suggest that gain-of-function of a
ene that promotes stem cell amplification can be applied
herapeutically to help overcome a major limitation in the
eld of regenerative medicine.
ethods
solation and Cell Culture
uman fetal hearts were harvested during elective pregnancy
ermination at the gestational ages of 19 to 22 weeks, in accor-
ance with the guidelines of the Institutional Human Research
thics Board of The Hospital for Sick Children and after obtaining
aternal consent.
The hearts were minced and washed with phosphate-buffered
aline. Cell isolation was accomplished with 0.2% trypsin and 1.0
g/mL type II collagenase in a 0.02% glucose phosphate-buffered
aline solution at 37°C. After dissection, cells were incubated on
recoated plastic culture dishes (Starstedt, Inc, Newton, NC) for
hours at 37°C to remove fibroblasts, with Iscove modified
ulbecco medium (IMDM; Gibco; Invitrogen Corporation, Carls-
ad, Calif) containing penicillin and streptomycin and supple-
ented with 10% fetal bovine serum (FBS; Gibco). After incuba-
ion, the supernatant was removed, added to precoated culture dishes
Sarstedt), and placed in a 5% carbon dioxide incubator at 37°C.
ene Transfer
ells were cultured to 60% to 70% confluency in preparation
Abbreviations and Acronyms
Ad.C  virus control
bFGF  basic fibroblast growth factor
CS  cardiosphere
DAPI  4,6-diamino-2-phenylindole
EGF  endothelial growth factor
FBS  fetal bovine serum
GFP  green fluorescent protein
GSK-3  glycogen synthase kinase-3
ILK  integrin-linked kinase
IMDM  Iscove modified Dulbecco mediumor adenovirally mediated infection of ILK constructs incorpo- w
The Journal of Thoracicating green fluorescent protein (GFP), as previously described.13
eplication-deficient serotype 5 adenovirus encoding either the
uman wild-type ILK gene (Ad.ILK-GFP) or empty virus con-
tructs incorporating a GFP tag (Ad.C), previously shown to modulate
LK expression and activity in L6 myoblasts,14 were used for the
nfection of cells. Cells were infected at 37°C at multiplicity of
nfection of 1.5 in IMDM with 10% FBS for 24 hours. Effective
ene transfer was confirmed by more than 80% of GFP positivity.
estern Blot Analysis
estern blot analysis was performed to confirm the transduction
f Ad.ILK in cardiac cell cultures. The cells were washed with
hosphate-buffered saline and harvested by scraping in lysis
uffer. After measurement of protein expression, analyses were
erformed with polyclonal anti-ILK antibody (Cell Signaling
echnology, Inc, Danvers, Mass). Proteins were visualized with an
nhanced chemiluminescence detection reagent (Amersham Phar-
acia Biotech, Piscataway, NJ) and quantified by densitometry.
mmunocytochemistry and Quantitative Analysis of
-Kit-positive Cells
ells were fixed with methanol at 20°C for 20 minutes. Cells
ere then reacted with c-Kit antibody (diluted 1:20; Assay De-
igns, Inc, Ann Arbor, Mich), human monoclonal the following:
nti-CD34 (Cymbus Biotechnology, Ltd, Eastleigh, Southampton,
nited Kingdom), human monoclonal anti--smooth muscle actin
1:100; Santa Cruz Biotechnology, Inc, Santa Cruz, Calif), human
olyclonal anti–von Willebrand factor (1:200), myosin monoclo-
al antibody (MF20 diluted 1:10), or monoclonal anti- actinin
1:200) from Sigma Chemical Company (St Louis, Mo). Nuclei
ere stained with 4,6-diamino-2-phenylindole (DAPI). All slides
ere analyzed at 20 magnification with a Leica fluorescent
icroscope with a coupled camera (Leica Microsystems GmbH,
etzlar, Germany). All analysis was done with OpenLab 4.0.2
oftware (Agilent Technologies, Scientific Software Inc, Palo Alto,
alif). More than 10 fields were randomly chosen and photo-
raphed, and the total cell number (5000/dish) was counted
anually in a fashion blinded to viral status.
eneration of Primary and Secondary Spheres
ell viability was confirmed with trypan blue staining before
lating at densities from 10 cells/L to 1 cell/L in 24-well plates.
he culture medium was composed of Dulbecco modified Eagle
edium/F-12 (1:1) including Hepes buffer (5 mmol/L), glucose
0.6%), sodium bicarbonate (3 mmol/L), glutamine (2 mmol/L),
nsulin (25 g/mL), transferrin (100 g/mL), progesterone (20
mol/L), putrescine (60 mol/L), sodium selenite (30 nmol/L),
uman recombinant endothelial growth factor (EGF; 20 ng/mL),
nd basic fibroblast growth factor (bFGF; 20 ng/mL). The number
f primary spheres generated in each well was assessed 14 days
fter plating. Primary spheres were dissociated into single cells
onsisting of approximately 200 to 500 cells, which were placed in
6-well plates. The number of secondary spheres was assessed 14
ays after replating dissociated cells.
ifferentiation Assay
econdary spheres were transferred to differentiation medium,
hich was composed of IMDM containing 10% FBS and 10
and Cardiovascular Surgery ● Volume 132, Number 6 1273
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Dmol/L 5-aza-2=-deoxycytodine (5azaD). Cells migrating out from
he spheres were analyzed by immunocytochemistry on day 14.
ells were fixed and characterized by staining with the following
arkers: -cardiac actinin antibody, MF20, directed to -cardiac
yosin heavy chain, von Willebrand factor antibody (diluted
:200; Dako, Glostrup, Denmark), or -smooth muscle actin an-
ibody (diluted 1:100; Santa Cruz).
esults
LK Increases the Frequency of c-Kit-positive Cells
o determine whether the overexpression of ILK increases
he stem cell number in the human heart, we acquired fetal
earts of gestational ages 19 to 22 weeks during elective
regnancy termination, and the hearts were enzymatically
issociated into single cell suspension. The cells were in-
ubated on precoated plastic culture dishes for 2 hours at
7°C to remove fibroblasts, which were shown to be devoid
f c-Kit-positive cells. At 2 to 3 days after isolation and at
0% to 70% confluency, cells were infected with replication
efective adenovirus containing wild-type (Ad.ILK) or vi-
us control (Ad.C). Effective gene transfer was confirmed
y more than 80% GFP positivity (Figure 1, A) and by
pproximately 3-fold increase in ILK protein expression
Figure 1, B) in cell cultures. Isolated c-Kit-positive cells
maged by fluorescence microscopy were typically negative
or the cardiac myosin markers -cardiac actinin (Figure 1, C),
F20, and the hematopoetic stem cell marker CD34. Cul-
f c-Kit-positive cells, which reached approximately one cell in 25
tandard error of the mean. GFP, green fluorescent protein; IMD
ntegrin-linked kinase.ures infected with wild-type ILK yielded a significant (P M
274 The Journal of Thoracic and Cardiovascular Surgery ● Dec001), approximately 5-fold increase in both the absolute
umber and the frequency of c-Kit-positive cells, which
eached approximately one cell in 250 (Figure 1, D).
uman Fetal Cardiac Cells Generate Cardiospheres
n Vitro
o determine whether primary human fetal cardiac cells
enerate cardiospheres (CSs) in vitro, cells were infected
ith Ad.ILK or Ad.C and plated in serum-free medium
upplemented with 20 ng/mL each of EGF and bFGF at
lonal density of a single cell per well in 24-well plates.
rimary CSs, comprised on morphologically homogeneous
ells, were reproducibly present at days 7 to 10 (Figure 2,
pper panel). CSs were noted to be uniformly free-floating,
resumably reflecting anchorage-independence, in distinc-
ion to cardiac myocytes, which became rapidly adherent to
he culture plate surface. Cells from dissociated primary
Ss were plated at a density corresponding to one sphere
200-400 cells) per well. Secondary CSs, which were
orphologically indistinguishable from primary CSs, were
vident in approximately 60% of wells at day 14 (Figure 2,
ower panel). CSs were shown to be composed of cells
xpressing the c-Kit-positive surface receptor (Figure 3).
Ss contained cells that invariably stained for c-Kit, often
ostaining with cardiac myosin markers -cardiac actinin or
Figure 1. Adenovirus encoding either
the human wild-type human gene
linked to GFP (AD.ILK) or empty virus
(Ad.C) was used to infect human fetal
cardiomyocytes cultured in IMDM
supplemented with 10% FBS. A, Effec-
tive gene transfer was confirmed by
more than 80% GFP positivity. B, ILK
infection increased ILK protein ex-
pression approximately 3-fold; the
Western blots shown are representa-
tive of 5 independent experiments.
GAPDH, Glyceraldehyde-3-phosphate
dehydrogenase. C, Cardiac cell cul-
tures labeled with c-Kit (green) and
cardiac myosin MF20 (red). Arrow in-
dicates c-Kit-positive cell. Nuclei
were stained with DAPI (blue). Scale
bar  10 mm. D, Cultures infected with
ILK yielded a significant (*P  .001)
approximately 5-fold increase in both
the absolute number and the frequency
alysis is based on 5 independent experiments. Error bars indicate
cove modified Dulbecco medium; FBS, fetal bovine serum; ILK,0. An
M, IsF20; in others the majority of cells stained exclusively for
ember 2006
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D-Kit with only occasional cells at the periphery of the spheres
taining for the cardiac marker -actinin (arrowhead).
LK Overexpression Increases the Rate of CS
ormation
LK infection of primary cardiac cell cultures resulted in a
reater number of primary spheres at each cell density tested,
ompared with untreated and virus controls (Figure 4, A).
mong CSs generated from ILK-infected cultures, approx-
mately 80% stained homogeneously for ILK-GFP; approx-
mately 20% exhibited no evidence of GFP staining; and no
pheres were observed that were mosaic for GFP, suggest-
ng origin from a single cell rather than cellular aggregation.
igure 3. CSs were composed of cells expressing the c-Kit-
ositive surface receptor. Occasional cells at the periphery of the
pheres stain for the cardiac marker -actinin (arrow), suggest-
ng a radial gradient in the differentiation of constituent cells.pSs, cardiospheres.
The Journal of Thoraciche frequency of sphere-initiating cells, as measured by the
atio of sphere number/total cell number, was significantly
reater in ILK-overexpressing cultures (Figure 4, B). The
requency of secondary or tertiary spheres generated from
rimary spheres composed of Ad.ILK, Ad.C, or uninfected
ells was highly similar (60% of wells), indicating that
hile ILK gain-of-function increases the formation of pri-
ary spheres, it does not alter their inherent capacity for
ubsequent self-renewal.
Cardiac stem cells are multipotent and have the capacity
o differentiate into smooth muscle, cardiac, and endothelial
ells.1,15,16 Secondary spheres were transferred to differen-
iation medium consisting of IMDM with 10% FBS and the
ethyltransferase inhibitor, 5azaD (10 mol/L). Within 4 to
days, spheres became attached to the plate and individ-
al cells migrated from spheres, which exhibited biochem-
cal evidence of differentiation into cardiomyocytes, smooth
uscle cells, and endothelial cells (Figure 5). The profile
f differentiated cells among ILK-overexpressing and con-
rol cells was highly similar (Figure 5, lower left panel),
ndicating that ILK-induced clonal proliferation of cardiac
tem cells does not impair their capacity for multilineage
ifferentiation.
iscussion
he heart contains several classes of primitive cells with the
apacity for regeneration based on differences in surface
ntigen expression reflecting variable degrees of differenti-
tion, as well as by variations in the isolation protocols that
ffect antigen expression.17 We identified cells derived from
Figure 2. Primary cardiospheres (CSs)
were generated from human fetal car-
diomyocytes grown in serum-free me-
dia supplemented with bFGF and EGF
(Methods) and imaged with natural
light phase microscopy. Dissociated
primary CSs composed of homoge-
neous phase-bright cells placed in
wells containing the same media gave
rise to secondary CSs in approximately
60% of wells. bFGF, basic fibroblast
growth factor; EGF, endothelial growth
factor.rimary cardiac tissue, which robustly stained for c-Kit anti-
and Cardiovascular Surgery ● Volume 132, Number 6 1275
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Den but not markers of cardiac differentiation. These cells
ere enriched in self-aggregating, anchorage-independent
pheres, which were shown to be clonogenic in derivative
assage. Further, the cells comprising the spheres exhibited
ult indicates the feasibility of manipulating the phenotypic outcom
ardiospheres; ILK, integrin-linked kinase; GFP, green fluore
,6-diamino-2-phenylindole.
276 The Journal of Thoracic and Cardiovascular Surgery ● Deche capacity to generate multiple cardiac cell lineages in
itro, confirming their identity as cardiac progenitor cells.
Several studies in the human heart have shown that c-Kit
epresents the most conserved marker for a progenitor cell
Figure 4. A, CSs were observed in hu-
man fetal cardiac cell cultures. Car-
diac cells were infected with adenovi-
ral ILK (Ad.ILK) or empty viral vector
(Ad.C) (at 10 pfu/mL) or left untreated
(Control). ILK infection resulted in sig-
nificant (*P < .01) increases in the
absolute number and frequency of CSs
at all plating densities tested. B, The
number of primary sphere-initiating
cells ratio was significantly higher in
ILK-infected cells (*P  .002).
Whereas 0.41%  0.073% of ILK-in-
fected cells generated spheres, only
0.037%  0.014% of control cells and
0.035%  0.006% of virus-only cells
generated spheres. Analysis is based
on 6 independent experiments. Error
bars represent standard error of the
mean. CSs, cardiospheres; ILK, inte-
grin-linked kinase.
Figure 5. A, Secondary CSs, derived
from cells isolated from a dissociated
primary CS, shown in upper left panel,
contains ILK-infected GFP-positive cells.
CSs were placed in differentiating me-
dium (IMDM  10% FBS) containing
the 5-methyltransferase inhibitor, 5azaD
(10 mol/L) for 14 days. B, Arrows in-
dicate CS-containing cells marked by
DAPI staining, which are also positive
for the cardiomyocyte-specific marker,
-cardiac actinin. Lower panel (left)
shows a higher-power view of cells
migrating outward from CSs, 45% to
50% of which are cardiomyocytes.
Lower panel (right) shows that approx-
imately 10% of CS-derived cells stain
positively (green) for von Willebrand
factor (vWF), indicative of endothelial
cell lineage. Thirty-five percent to 40%
of cells stained positively for -smooth
muscle actin (SMA) (not shown). C,
The differentiation profiles were simi-
lar among ILK-infected (Ad.ILK), empty
virus (AD.C), and control CSs. This re-
cardiac progenitor cells, even among ILK-transformed cells. CSs,
t protein; IMDM, Iscove modified Pulbecco medium; DAPI,e of
scenember 2006
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Dopulation, with the properties of self-renewal, clonogenic-
ty, and multipotency.1,16-18 The proto-oncogene c-Kit en-
odes a transmembrane tyrosine kinase receptor, and the
igand for c-Kit has been identified to be stem cell factor.19
he capacity of c-Kit-positive clonogenic cells to generate
ardiac cell lineages in vitro and to regenerate myocardium
fter experimental myocardial infarction1 and ischemia-
eperfusion in vivo is superior to that of Sca-1-positive or
DR-1–like cells.20 Accordingly, we relied on c-Kit ex-
ression to mark a cardiac progenitor cell population in
uman fetal myocardium, in order to determine the influ-
nce of ILK gain-of-function on cardiac stem cell prolifer-
tion. Although we did not perform comprehensive antigen
rofiling on cardiac progenitor cells isolated via our proto-
ol, we did not identify cells that immunostained for islet-1,
hich is a transcription factor associated with commitment
o the cardiomyocyte lineage previously described in the
ewborn human heart,21 nor did we identify cells that ex-
ressed the hematopoetic stem cell marker CD34. The latter
esult suggests that CSs were derived from a cardiac resi-
ent, rather than from a bone marrow–mobilized, cellular
opulation.22
We postulated that human fetal cardiac tissue would be
nriched for stem cells, which are important during cardio-
enesis.21 Inasmuch as it has been reported that cardiac
-Kit-positive cells can differentiate into the various cardiac
ineages, including cardiomyocytes, smooth muscle, and
ndothelial cells,3 c-Kit antibody was used as a marker for
ardiac stem cells. We took advantage of the tendency of
ardiac cells to form macroscopic CSs when grown on non-
dhesive substrata in the presence of growth factor supple-
entation. Using the capacity to form CSs as a readout for
tem cell frequency, we tested whether adenoviral ILK
verexpression would cause proliferation of CS-forming
ells with self-renewal, clonogenic, and multidifferentiation
roperties.
c-Kit-positive cells occur either as isolated cells or in the
orm of macroscopic CSs, analogous to neurospheres con-
aining c-Kit-positive, multipotent neural stem cells.23,24
Ss have been previously characterized as lineage-negative,
-Kit-positive, morphologically homogeneous cells, having
he capacity for self-renewal as well as differentiation into
unctional cardiac myocytes, and to participate in the regen-
ration of functional myocardium in vivo.15 Immunostain-
ng revealed that constituent cells contained in spheres,
lthough invariably c-Kit-positive, sometimes possessed
arcomeric structures as assessed by antibody labeling di-
ected to cardiac markers such as MF20 and -cardiac
ctinin. This finding raises the possibility that CSs represent
lusters of terminally differentiated cardiac myocytes un-
ergoing cellular replication by mitoses, rather than bona
de cardiac progenitor cells. However, our findings arguehat the c-Kit-positive, -cardiac actinin–positive cells in a
The Journal of ThoracicSs represent the progeny by asynchronous cellular divi-
ion of an undifferentiated c-Kit-positive progenitor cell.
his interpretation holds that the variable expression of
ardiomyocyte markers present in the spheres reflects vari-
ble degrees of lineage commitment among constitutent
ells and their progeny. It is supported by our results, which
emonstrate the capacity of CSs to exhibit multilineage differ-
ntiation into smooth muscle, cardiac, and endothelial cells
n response to 5azaD exposure, as described previously.15
The evolutionarily conserved canonical Wnt pathway
as been implicated in both human and mouse embryonic
tem cell self-renewal competence.11 The Wnt/-catenin
ignaling pathway is required for maintaining proliferation
f neuronal progenitors12 and for hematopoietic stem cell
omeostasis. ILK negatively modulates of GSK-3 ac-
ivity, promotes nuclear activation of -catenin,12,25,26 and
s a candidate kinase activator of Wnt pathway signaling5
Figure 6). ILK overexpression or constitutive activation
romotes cell cycle transit through a signaling pathway
omprising the Wnt components GSK-3ß and ß-catenin,
eading to increased expression of cyclin D127 and provid-
ng a molecular basis for the inherent proliferation (self-
enewal) property of stem cells. Moreover, ILK promotes
igure 6. ILK is a multifunctional protein kinase that coordinates
ignal transduction by integrins and growth factor receptor ty-
osine kinases (RTKs). ILK negatively modulates GSK-3 activity,
romotes nuclear activation of -catenin, and is a candidate
inase activator of canonical Wnt pathway signaling. ILK pro-
otes anchorage-independent survival and cell cycle transit as a
esult of cyclin D activation, providing a potential molecular
asis for both oncogenesis and stem cell self-renewal. ILK,
ntegrin-linked kinase; GSK-3, glycogen synthase kinase-3.nchorage-independent survival, which appears to be a ge-
and Cardiovascular Surgery ● Volume 132, Number 6 1277
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Deric and poorly understood feature of stem cells, including
-Kit-containing CSs isolated from adult rat1 and human
earts.15
This study demonstrates that self-renewing CSs gener-
ted from human fetal cardiac cells are composed of cells
xhibiting the properties of stem cells, including the capac-
ty for self-renewal and multilineage differentiation. This
esult has also been reported for putative cardiac stem cells
n cardiac cells isolated from adult rodent,1 murine,16 and
uman atrial biopsies.15 Overexpression of ILK resulted
n an approximately 10-fold increase in the frequency of
phere-initiating cells. Importantly, ILK-transformed stem
ells are shown to be equally susceptible to cardiac differ-
ntiation, even while exhibiting an increased capacity for
roliferation and CS formation.
ILK is positioned to transduce distinct signal inputs from
ntegrins and growth factor receptor tyrosine kinases,28,29 is
n activator of the Wnt pathway,6 and promotes anchorage-
ndependent cellular proliferation,5,7 thus providing a puta-
ive molecular basis for the observed amplification effect
n the cardiac stem cell population. An ILK-dependent
ncrease in cardiac stem cell frequency is consistent with
he finding that vascular endothelial growth factor has
een shown to positively regulate hematopoetic stem cell
urvival,30 since ILK positively regulates vascular endothe-
ial growth factor expression through a hypoxia-inducible
actor-1–dependent pathway.4 The fact that ILK effect
as evident even under conditions of growth factor supple-
entation supports the rationale of exploiting upregulation
f the ILK signaling pathway as a novel strategy to promote
herapeutically useful expansion of a target stem cell popu-
ation.
In summary, these experiments identify ILK as a novel
olecular target impinging on cardiac stem cell amplifica-
ion. These findings have important therapeutic implications
or potential ex vivo manipulation of cardiac stem cells in
onjunction with cellular transplantation, and they also an-
icipate future strategies designed to exploit the recruitment
f endogenous cardiac progenitor cells.
imitations
ore definitive characterization of the phenotype and state
f commitment of cells comprising CSs toward the cardio-
yocyte lineage, and the effect of ILK gain-of-function on
hese cells, will require further profiling with cardiac stem
ell markers such as islet-1,21 as well as earlier (Nkx2.5)
ardiac genes, in addition to more mature cardiac genes
Mef2c, -actinin) surveyed in this study. Methods incor-
orating fluorescent tags linked to promoter regions of early
ardiac genes would help to further confirm the differenti-
tion potential of CSs and the effects of ILK gene transfer
n the capacity for symmetric versus asymmetric cellular
ivision generating terminally differentiated cardiac cells.
2
278 The Journal of Thoracic and Cardiovascular Surgery ● Decurther, the specific ILK-regulated signaling pathways that
overn self-renewal and differentiation in this unique stem
ell population await clarification.
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iscussion
r Frank W. Sellke (Boston, Mass). This is a very nice in vitro
tudy of the effects of overexpression of ILK on cardiac stem cell
rowth.
I have a couple questions. Was the purpose of this study just to
ncrease expansion of the stem cell population, or do you think that
t perhaps could overcome some of the negative influences of
schemia, diabetes, and similar issues on stem cell engraftment and
unction?
Second, do you have any evidence from in vivo studies that this
ill be translated into a physiologic or potentially a clinical ben-fit? s
The Journal of ThoracicFinally, how does this treatment potentially affect the pheno-
ype of the cells or function of the actual cells, other than what you
ave described here?
Dr Coles. Thank you for those insightful questions. The first
wo seem to pertain to the in vivo effect of the cells, and we have
ot had the opportunity to transplant the CSs into a mouse model
f severe combined immunodeficiency, for example, to see what
appens to them in vivo, in terms of their differentiation, or their
esistance to ischemic injury. We would predict that ILK gain-of-
unction, since it is a pro-survival gene, would tend to oppose
schemic damage to the cells.
The focus of this in vitro study was to identify the effect of this
ovel kinase on signaling in human cardiac progenitor cells and to
ry to understand the biology regarding ILK-mediated self-renewal
ersus differentiation. There is a lot more work to be done to try
o nail down the signaling node elements in these progenitor cells
hat determine their phenotypic outcome.
One of the concerns, of course, is that ILK is an oncogene, so
e would probably, in terms of ultimate clinical application, want
o look for small molecule agonists of ILK rather than using the
ene per se.
We do have something in our favor: Cardiac cells are inher-
ntly resistant to oncogenesis, so that we probably have some more
atitude in terms of driving these cells to a pro-survival state.
Taken together, our data, although in vitro, indicate that ILK
epresents a novel and potentially useful target in cardiac progen-
tor cell signaling.
Dr Paul A. Kurlansky (Miami, Fla). Cardiomyocytes are
nder extreme control, not even in an ischemic situation but just in
he regular situation. The regulation of stem cell development is
bviously extremely tightly controlled. Do you have any insight as
o how this promoter might interact with the control mechanisms
hat exist just in the normal adult heart?
Dr Coles. We know that ILK is present in normal cardiac
issue. Obviously, in these experiments, all we can conclude is that
hen you overexpress the gene, it tends to drive the cells into a
elf-renewal mode and/or to promote asynchronous division into
erminally differentiated cardiac cells. Whether or not it is acti-
ated, let’s say, in response to an endogenous myocardial damage
ignal, we do not know that in vivo.
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